P Auger

589 total citations
23 papers, 272 citations indexed

About

P Auger is a scholar working on Epidemiology, Infectious Diseases and Microbiology. According to data from OpenAlex, P Auger has authored 23 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 9 papers in Infectious Diseases and 4 papers in Microbiology. Recurrent topics in P Auger's work include Antifungal resistance and susceptibility (8 papers), Infective Endocarditis Diagnosis and Management (5 papers) and Fungal Infections and Studies (5 papers). P Auger is often cited by papers focused on Antifungal resistance and susceptibility (8 papers), Infective Endocarditis Diagnosis and Management (5 papers) and Fungal Infections and Studies (5 papers). P Auger collaborates with scholars based in Canada and France. P Auger's co-authors include S Montplaisir, Arnaud Attyé, M Pelletier, S. Garzón, Errol Reiss, Leo Kaufman, Sandra L. Bragg, R J Kuykendall, Wayne S. Lapp and Louis de Repentigny and has published in prestigious journals such as Cancer Research, Journal of Clinical Microbiology and Infection and Immunity.

In The Last Decade

P Auger

20 papers receiving 253 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Auger Canada 10 170 128 49 35 25 23 272
F Mateička Slovakia 10 160 0.9× 169 1.3× 30 0.6× 28 0.8× 37 1.5× 25 321
A Tomsíková Czechia 8 163 1.0× 166 1.3× 31 0.6× 20 0.6× 14 0.6× 52 272
Carlyn Halde United States 12 224 1.3× 182 1.4× 65 1.3× 36 1.0× 26 1.0× 35 376
I. G. Murray United Kingdom 15 237 1.4× 178 1.4× 52 1.1× 70 2.0× 23 0.9× 31 560
C M L Maffei Brazil 13 315 1.9× 201 1.6× 71 1.4× 53 1.5× 79 3.2× 16 444
Michael A. Petrou United Kingdom 10 191 1.1× 223 1.7× 54 1.1× 29 0.8× 15 0.6× 17 442
Pascale Huynen Belgium 11 96 0.6× 127 1.0× 25 0.5× 40 1.1× 20 0.8× 23 339
M. Monod Switzerland 8 236 1.4× 174 1.4× 107 2.2× 56 1.6× 10 0.4× 10 366
Younes Maaroufi Belgium 10 188 1.1× 168 1.3× 46 0.9× 74 2.1× 11 0.4× 15 413
A. Marot-Leblond France 10 165 1.0× 250 2.0× 21 0.4× 76 2.2× 26 1.0× 15 345

Countries citing papers authored by P Auger

Since Specialization
Citations

This map shows the geographic impact of P Auger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Auger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Auger more than expected).

Fields of papers citing papers by P Auger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Auger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Auger. The network helps show where P Auger may publish in the future.

Co-authorship network of co-authors of P Auger

This figure shows the co-authorship network connecting the top 25 collaborators of P Auger. A scholar is included among the top collaborators of P Auger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Auger. P Auger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Noviski, Mark, Stephanie Yung, Jordan Ye, et al.. (2023). Abstract 2850: NX-5948 promotes selective, sub-nanomolar degradation of inhibitor-resistant BTK mutants. Cancer Research. 83(7_Supplement). 2850–2850. 2 indexed citations
2.
Auger, P, et al.. (2009). Study of some Factors Influencing the Growth of Candida Albicans in Vitro. Mycoses. 21(3). 63–70. 1 indexed citations
3.
Auger, P, et al.. (2001). Predictive value of Candida colonization index in 131 patients undergoing two different cardiovascular surgical procedures.. PubMed. 42(3). 339–43. 11 indexed citations
4.
Sénéchal, Serge, et al.. (1996). Candida albicans serotype analysis by flow cytometry. Journal of Clinical Microbiology. 34(9). 2106–2112. 15 indexed citations
5.
Auger, P, et al.. (1993). Epidemiology of tinea pedis in marathon runners: prevalence of occult athlete's foot. Mycoses. 36(1-2). 35–41. 61 indexed citations
6.
7.
Poirier, Steve, et al.. (1990). Interest of Biotyping Candida albicans in Chronic Vulvovaginitis. Mycoses. 33(1). 24–28. 10 indexed citations
8.
Attyé, Arnaud, et al.. (1990). INCIDENCE OF OCCULT ATHLETE'S FOOT IN SWIMMING POOLS. 6(3). 244–247. 1 indexed citations
9.
10.
Montplaisir, S, et al.. (1988). Genetics of resistance to infection with Candida albicans in mice.. PubMed. 69(5). 651–60. 26 indexed citations
11.
Reiss, Errol, Louis de Repentigny, R J Kuykendall, et al.. (1986). Monoclonal antibodies against Candida tropicalis mannan: antigen detection by enzyme immunoassay and immunofluorescence. Journal of Clinical Microbiology. 24(5). 796–802. 37 indexed citations
12.
Auger, P, et al.. (1986). Antibioprophylaxie de l'endocardite infectieuse lors de manipulations dentaires. Médecine et Maladies Infectieuses. 16(10). 543–547.
13.
Montplaisir, S, et al.. (1985). Genetic resistance to murine cryptococcosis: the beige mutation (Chédiak-Higashi syndrome) in mice. Infection and Immunity. 47(1). 288–293. 14 indexed citations
14.
Montplaisir, S, et al.. (1985). Genetic resistance to murine cryptococcosis: increased susceptibility in the CBA/N XID mutant strain of mice. Infection and Immunity. 47(1). 282–287. 32 indexed citations
15.
Auger, P, et al.. (1985). Endocardite infectieuse à Actinobacillus actinomycetemcomitans. La Revue de Médecine Interne. 6(5). 515–521. 3 indexed citations
16.
Baillot, Richard, et al.. (1984). Early valve replacement in active infective endocarditis.. PubMed. 27(4). 383–6. 8 indexed citations
17.
Auger, P, et al.. (1982). Rifampin therapy for Staphylococcus epidermidis endocarditis.. PubMed. 127(7). 609–10. 1 indexed citations
18.
Auger, P, et al.. (1980). Stunted growth Candida albicans in human amniotic fluid in vitro.. PubMed. 95(2). 272–81. 5 indexed citations
19.
Auger, P, et al.. (1971). [Anatomopathological study of joint chondrocalcinosis. 11 cases].. PubMed. 79(16). 707–10. 4 indexed citations
20.
Martineau, B, et al.. (1971). [Incidence of superficial mycotic infections at Sainte-Justine Hospital, Montreal].. PubMed. 100(12). 2345–50.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F Mateička Breakdown of academic impact, for papers by A Tomsíková Breakdown of academic impact, for papers by Carlyn Halde Breakdown of academic impact, for papers by I. G. Murray Breakdown of academic impact, for papers by C M L Maffei Breakdown of academic impact, for papers by Michael A. Petrou Breakdown of academic impact, for papers by Pascale Huynen Breakdown of academic impact, for papers by M. Monod Breakdown of academic impact, for papers by Younes Maaroufi Breakdown of academic impact, for papers by A. Marot-Leblond
Rankless by CCL
2026